Dr Reddy's Q2 results: Net profit rises 33% to Rs 1,482 cr

Consolidated quarterly revenue rose 9% to Rs 6,903 crore led by a 9% growth in the key global generics segment

Related Keywords

India ,United States ,Hyderabad ,Andhra Pradesh ,America ,American , ,Bristol Myers Squibb ,Dr Reddy Laboratories Inc ,Cipla ,Laboratories Inc ,North American ,Nifty Pharma ,Dr Reddy 039 S ,R Reddy 039s Q2 Results ,R Reddy 039s Net Profit ,R Reddy 039s Quarterly Revenue ,Dr Reddy 039s Laboratories ,